Dongmei Yan

1.7k total citations
73 papers, 1.3k citations indexed

About

Dongmei Yan is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Dongmei Yan has authored 73 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 21 papers in Immunology and 13 papers in Cancer Research. Recurrent topics in Dongmei Yan's work include Immune cells in cancer (15 papers), Nanoplatforms for cancer theranostics (9 papers) and MicroRNA in disease regulation (8 papers). Dongmei Yan is often cited by papers focused on Immune cells in cancer (15 papers), Nanoplatforms for cancer theranostics (9 papers) and MicroRNA in disease regulation (8 papers). Dongmei Yan collaborates with scholars based in China, United States and France. Dongmei Yan's co-authors include Zheng Jin, Dong Li, Xun Zhu, Chunyan Duan, Rongyang Dai, Pei Zhu, Chang Shu, Yuan‐Di Zhao, Xiaoquan Yang and Jitao Song and has published in prestigious journals such as Nano Letters, PLoS ONE and Biomaterials.

In The Last Decade

Dongmei Yan

69 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongmei Yan China 23 681 252 242 219 186 73 1.3k
Xiaoyan Wu China 28 1.3k 1.9× 365 1.4× 529 2.2× 179 0.8× 167 0.9× 66 2.1k
Jong‐Min Jeong South Korea 14 956 1.4× 230 0.9× 164 0.7× 164 0.7× 94 0.5× 29 1.7k
Yan Dong China 22 518 0.8× 178 0.7× 213 0.9× 181 0.8× 109 0.6× 113 1.4k
Dan Zhong China 18 775 1.1× 130 0.5× 563 2.3× 282 1.3× 102 0.5× 47 1.3k
Min Jiao China 20 718 1.1× 151 0.6× 250 1.0× 207 0.9× 145 0.8× 82 1.5k
Cheolhee Won South Korea 19 577 0.8× 197 0.8× 144 0.6× 132 0.6× 88 0.5× 33 1.0k
Lulu Han China 24 702 1.0× 192 0.8× 215 0.9× 303 1.4× 199 1.1× 79 1.5k
Chenguang Fan United States 31 2.1k 3.0× 313 1.2× 197 0.8× 117 0.5× 279 1.5× 58 2.9k
Byoung Chul Park South Korea 30 1.6k 2.3× 267 1.1× 215 0.9× 106 0.5× 120 0.6× 107 2.3k
Xiangping Liu China 19 662 1.0× 130 0.5× 253 1.0× 144 0.7× 114 0.6× 95 1.3k

Countries citing papers authored by Dongmei Yan

Since Specialization
Citations

This map shows the geographic impact of Dongmei Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongmei Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongmei Yan more than expected).

Fields of papers citing papers by Dongmei Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongmei Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongmei Yan. The network helps show where Dongmei Yan may publish in the future.

Co-authorship network of co-authors of Dongmei Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Dongmei Yan. A scholar is included among the top collaborators of Dongmei Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongmei Yan. Dongmei Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bai, Li, Chao Liu, Yang Lü, et al.. (2024). Ti2C3 MXene-based nanocomposite as an intelligent nanoplatform for efficient mild hyperthermia treatment. Journal of Colloid and Interface Science. 665. 389–398. 16 indexed citations
2.
Yan, Dongmei & Huilan Yi. (2024). Transcriptome analysis provides insights into preservation mechanism of postharvest Muscat Hamburg grapes treated with SO2. Scientia Horticulturae. 331. 113108–113108. 10 indexed citations
3.
Lü, Yang, Xiaomin Liu, Dongmei Yan, et al.. (2024). Fluorescent/Circular Dichroic Dual-Mode Chiral Upconversion Nanocomposite for Diagnosis and Treatment of Rheumatoid Arthritis. Nano Letters. 24(48). 15331–15339. 4 indexed citations
4.
Xu, Linyan, et al.. (2023). A Combination of CPI-0610 and SAHA Induces Apoptosis through STAT3 and p38 Signalling Pathways in Diffuse Large B-cell Lymphoma Cells. Current Medicinal Chemistry. 32(8). 1589–1605. 3 indexed citations
5.
Wang, Yinan, et al.. (2023). NMAAP1 regulated macrophage polarizion into M1 type through glycolysis stimulated with BCG. International Immunopharmacology. 126. 111257–111257. 10 indexed citations
6.
Wang, Yinan, et al.. (2023). PDGFRA exhibits potential as an indicator of angiogenesis within the tumor microenvironment and is up-regulated in BLCA. Microvascular Research. 151. 104614–104614. 3 indexed citations
7.
Jin, Zheng, et al.. (2022). The role of TRIM59 in immunity and immune-related diseases. International Reviews of Immunology. 43(1). 33–40. 7 indexed citations
8.
Yan, Dongmei, et al.. (2020). The novel target:exosoms derived from M2 macrophage. International Reviews of Immunology. 40(3). 183–196. 22 indexed citations
9.
Ma, Xiaohui, et al.. (2020). BCG-induced trained immunity in macrophage: reprograming of glucose metabolism. International Reviews of Immunology. 39(3). 83–96. 23 indexed citations
10.
Xu, Linyan, Xiang Gao, Yang Pu, et al.. (2020). EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells. Journal of Cancer. 12(4). 1011–1022. 8 indexed citations
11.
Zhu, Pei, Shanshan Liu, Zheng Jin, et al.. (2019). IL-4-polarized BV2 microglia cells promote angiogenesis by secreting exosomes. Advances in Clinical and Experimental Medicine. 28(4). 421–430. 87 indexed citations
12.
Shi, Kai, et al.. (2018). MiR-203 regulates keloid fibroblast proliferation, invasion, and extracellular matrix expression by targeting EGR1 and FGF2. Biomedicine & Pharmacotherapy. 108. 1282–1288. 45 indexed citations
13.
Yan, Dongmei, et al.. (2017). WBSCR22 confers oxaliplatin resistance in human colorectal cancer. Scientific Reports. 7(1). 15443–15443. 43 indexed citations
14.
Li, Dong, Xiuzhu Gao, Jingmin Gu, et al.. (2016). A Novel Application of Ti-Substituted Polyoxometalates: Anti-Inflammatory Activity in OVA-Induced Asthma Murine Model. Bioinorganic Chemistry and Applications. 2016. 1–9. 9 indexed citations
15.
Dai, Rongyang, Dongmei Yan, Juan Li, et al.. (2012). Activation of PKR/eIF2α signaling cascade is associated with dihydrotestosterone‐induced cell cycle arrest and apoptosis in human liver cells. Journal of Cellular Biochemistry. 113(5). 1800–1808. 31 indexed citations
16.
Zhao, Xiangfeng, Qihui Liu, Peng Li, et al.. (2012). A Novel Accessory Molecule Trim59 Involved in Cytotoxicity of BCG-Activated Macrophages. Molecules and Cells. 34(3). 263–270. 19 indexed citations
17.
Dai, Rongyang, et al.. (2011). Unfolded Protein Response Suppresses Cisplatin-Induced Apoptosis via Autophagy Regulation in Human Hepatocellular Carcinoma Cells. Folia Biologica. 57(3). 87–95. 56 indexed citations
18.
Dai, Rongyang, et al.. (2010). PI3K/Akt Promotes GRP78 Accumulation and Inhibits Endoplasmic Reticulum Stress-Induced Apoptosis in HEK293 Cells. Folia Biologica. 56(2). 37–46. 37 indexed citations
19.
Dai, Rongyang, Juan Li, Youping Liu, et al.. (2010). miR-221/222 suppression protects against endoplasmic reticulum stress-induced apoptosis via p27Kip1- and MEK/ERK-mediated cell cycle regulation. Biological Chemistry. 391(7). 791–801. 50 indexed citations
20.
Yan, Dongmei, et al.. (2007). Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing.. PubMed. 4(5). 359–67. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026